BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEMENTIA RESEARCHER - ECPv6.14.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DEMENTIA RESEARCHER
X-ORIGINAL-URL:https://www.dementiaresearcher.nihr.ac.uk
X-WR-CALDESC:Events for DEMENTIA RESEARCHER
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260409
DTEND;VALUE=DATE:20260411
DTSTAMP:20260413T010602
CREATED:20260113T215051Z
LAST-MODIFIED:20260113T215051Z
UID:10002046-1775692800-1775865599@www.dementiaresearcher.nihr.ac.uk
SUMMARY:DSAD - ASAD Conference
DESCRIPTION:This is the third edition of this groundbreaking conference\, which aims to foster collaboration and knowledge exchange between the fields of Down Syndrome associated Alzheimer disease (DSAD) and autosomal dominant AD (ADAD). \nThe event will feature research findings\, clinical trials\, and more\, with an inclusive approach to diversity\, representation\, and accessibility. \n\n\n\n\nThis conference will be a seminal event in advancing the understanding and treatment of Alzheimer’s disease (AD)\, particularly by bridging the fields of Down Syndrome Alzheimer’s disease (DSAD) and Autosomal Dominant Alzheimer’s disease (ADAD). It emphasizes collaboration\, ethical considerations\, and inclusivity\, fostering a unified approach to tackling both conditions. \nA key focus of the conference will be creating lasting networks and collaborations\, ensuring that the dialogue and progress continue well beyond the event itself. Building on the success of the previous conferences\, which attracted close to 200 in-person attendees and many more online from over 20 countries\, this third conference aims to expand on that momentum. In addition to the strong support from the DSAD research community\, we have renowned international ADAD speakers\, with outreach through the DIAN network. The event will promote cross-fertilization of ideas\, highlighting the potential for shared insights between these genetically determined forms of AD. This is particularly timely as we now have several ongoing drug development projects in both DSAD and ADAD\, with more planned. The exchange of ideas between researchers in these areas is crucial for maximizing the impact of therapeutic strategies. \nIn conclusion\, the conference will cultivate a collaborative\, diverse\, and inclusive environment to advance research in DSAD and ADAD. The collective expertise of the organizing and scientific committee\, combined with support from key stakeholders in Alzheimer’s research\, will ensure a successful and impactful event. This gathering represents a significant step forward in global AD research\, providing a dynamic platform that fosters connections\, innovation\, and progress in understanding and treating these intertwined conditions. \nAttendees\, Inclusivity & Collaboration Strategy to promote Diversity\, Equity\, and Inclusion: \n\nIntended Audience: Targeting a diverse group of students\, researchers\, clinicians\, experts\, policy-makers\, and other stakeholders interested in genetically determined AD.\nSelection Process & Inclusivity: Striving for a balanced and diverse program\, selecting top communications from a wide range of contributors.\nGender Balance & Ethnic and Geographical Diversity: Aiming for balanced representation of gender among speakers\, moderators\, and attendees. Actively promoting participation from various ethnic backgrounds and geographical regions.\nEarly and Senior Researchers: Ensuring a mix of early-career and senior researchers in all sessions.\nSupport for Attendees with Families: Provision of daycare services to support those with childcare responsibilities and enable their attendance.\n\nFind out More
URL:https://www.dementiaresearcher.nihr.ac.uk/event/dsad-asad-conference/
LOCATION:Modernist Hospital of Sant Pau\, Sant Antoni Maria Claret Street\, 16\, Barcelona\, Spain
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/01/DSAD-ADAD.png
GEO:41.4031935;2.1639358
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Modernist Hospital of Sant Pau Sant Antoni Maria Claret Street 16 Barcelona Spain;X-APPLE-RADIUS=500;X-TITLE=Sant Antoni Maria Claret Street\, 16:geo:2.1639358,41.4031935
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260410T080000
DTEND;TZID=Europe/London:20260410T090000
DTSTAMP:20260413T010602
CREATED:20260323T091014Z
LAST-MODIFIED:20260323T091014Z
UID:10002154-1775808000-1775811600@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Designing Clinical Trials for Dementia-Risk Cohorts
DESCRIPTION:Register for the Workshop: Designing Clinical Trials for Dementia-Risk Cohorts: Practical Strategies for Success \nThursday 10 April 2026\, 9:00 – 10:30AM CEST \nRegister your details below before April 1. Please be aware that number of participants is limited. We will send the Zoom meeting details to selected participants before April 7.  Please note that this workshop will be delivered in English language. \nConducted in partnership with: Jena University Hospital (Germany)\, Vilnius University (Lithuania)\, Rīga Stradiņš University (Latvia)\, Western Sydney University (Australia). \nWhat you’ll learn: \n\nClinical trial design choices\nCognitive & functional endpoints that balance sensitivity and burden\nDecentralised vs. onsite trade-offs\, biosample & neuroimaging workflows\nPiloting/feasibility methods and mixed‑methods to boost recruitment & retention\n\nIdeal for investigators planning early‑phase or prevention trials. \nFacilitated by: A/Prof Genevieve Steiner-Lim\, Najwa-Joelle Metri\, Lauren Dewsbury & Rose Mery Bou Merhy. \n\nRegister
URL:https://www.dementiaresearcher.nihr.ac.uk/event/designing-clinical-trials-for-dementia-risk-cohorts/
LOCATION:Online\, United Kingdom
CATEGORIES:Online
ATTACH;FMTTYPE=image/jpeg:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2026/03/1774003275801-e1774256950717.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260410T120000
DTEND;TZID=Europe/London:20260410T130000
DTSTAMP:20260413T010602
CREATED:20260206T120220Z
LAST-MODIFIED:20260206T120220Z
UID:10002088-1775822400-1775826000@www.dementiaresearcher.nihr.ac.uk
SUMMARY:PPA Awareness Day 2026 Webinar
DESCRIPTION:Primary Progressive Aphasia (PPA) is a rare language led dementia. People with PPA have told us that it can be difficult to get an accurate diagnosis and to get the right support. \nThe 2026 awareness campaign aims to increase knowledge about PPA and what the right supports might be\, and this year is delivered is a collaboration with the Royal College of Speech and Language Therapists\, Rare Dementia Support and the Memory Services National Accreditation Programme (MSNAP). MSNAP is a quality improvement network under the Royal College of Psychiatrists that accredits UK dementia services. \nThe campaign will run for 10-weeks. Each Friday we will share news\, personal anecdotes from people with lived experience or updates on research via social media. \nThe campaign will culminate in a webinar at midday on PPA Awareness Day – Friday 10th April. \nThe webinar is for everyone and will include short presentations from: \n\na world leading neurologist\nspeech and language therapists\nrepresentatives from Rare Dementia Support and MSNAP\npeople with lived experience\n\nRegister to Attend
URL:https://www.dementiaresearcher.nihr.ac.uk/event/ppa-awareness-day-2026-webinar/
LOCATION:Online\, United Kingdom
CATEGORIES:Online
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2025/02/Primary-Progressive-Aphasia-Awareness-Day.png
END:VEVENT
END:VCALENDAR